Back

lipid profile and incidence of atrial fibrillation: results from the Kailuan Study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Demographics and screening Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Yunlong Xia

First Affiliated Hospital of Dalian Medical University, Dalian (China)

11 More presentations in this session

Presentation thumbnail
Screening for atrial fibrillation in the primary health care setting
Doctor F. Ghazal (Stockholm, SE)
Abstract Slides
Presentation thumbnail
How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting
Mrs T. Lobban (Oxford, GB)
Abstract Slides
Presentation thumbnail
Benefits of active involvement of community pharmacists in know your pulse awareness campaign
Doctor S. Antoniou (London, GB)
Abstract Slides
Presentation thumbnail
Prevalence rates of atrial fibrillation tentatively increased during and after the Great East Japan earthquake.
Doctor K. Tamaki (Morioka, JP)
Abstract Slides
Presentation thumbnail
Risk for adverse outcome events according to paroxysmal vs. non-paroxysmal atrial fibrillation
Doctor S. Blum (Basel, CH)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Demographics and screening

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources